Tanvex BioPharma completes acquisition of Bora Biologics, Expanding Global Biologics Development Capabilities
Acquiring Company
Tanvex BioPharma
Acquired Company
Bora Biologics
San DiegoManufacturingBiotechnologyManufacturingBiotechnologyBiopharmaDescription
Tanvex BioPharma, Inc. announces the successful completion of its acquisition of Bora Biologics, formerly a subsidiary of Bora Pharmaceuticals. The acquisition aims to combine Tanvex's expertise in biosimilar development and commercialization with Bora's extensive global early-stage biologics CDMO capabilities, empowering the newly formed Bora Biologics to deliver comprehensive end-to-end solutions for biologics customers worldwide.
Quick answer
Tanvex BioPharma is acquiring Bora Biologics, announced January 19, 2025. Tanvex BioPharma is based in San Diego, California, United States.
- How much did Tanvex BioPharma pay for Bora Biologics?
- The deal value was not disclosed.
- What does Tanvex BioPharma do?
- Tanvex BioPharma USA, Inc is a biologic pharmaceutical product development and manufacturing organization aiming to provide high quality, value added capabilities to accelerate the introduction of biologic therapeutics..
- Where are Tanvex BioPharma and Bora Biologics based?
- Tanvex BioPharma is based in San Diego, California, United States.
- Who are the decision-makers at Tanvex BioPharma?
- Fundz holds 3 contacts at Tanvex BioPharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Biopharma and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie completes acquisition of Nimble Therapeutics to expand its immunology pipeline (January 23, 2025)
- AbbVie completes acquisition of Aliada Therapeutics to enhance neuroscience development (December 11, 2024)
- Momentum Biotechnologies acquires OmicScouts (March 5, 2025)
- Oklo acquires Atomic Alchemy for $25 million, $25M (March 5, 2025)
- Sudarshan Chemical acquires Heubach Group (March 4, 2025)
- Sandvik acquires CIMCO's probing technology and resellers (March 3, 2025)
Who to call at Tanvex BioPharma, and when
When Tanvex BioPharma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Tanvex BioPharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tanvex BioPharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tanvex BioPharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tanvex BioPharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Bora Biologics?
Bora Biologics was acquired by Tanvex BioPharma, based in San Diego. The deal was reported on January 19, 2025. Tanvex BioPharma is privately held and operates in Manufacturing.
When did Tanvex BioPharma acquire Bora Biologics?
Tanvex BioPharma's acquisition of Bora Biologics was reported on January 19, 2025. Tanvex BioPharma, Inc. announces the successful completion of its acquisition of Bora Biologics, formerly a subsidiary of Bora Pharmaceuticals. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Bora Biologics do?
Bora Biologics, formerly a subsidiary of Bora Pharmaceuticals, offers extensive global early-stage biologics CDMO capabilities in Taiwan, with a proven track record of over 100 successful cGMP manufacturing batches. It is privately held, operating in Manufacturing.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.